José M. Herranz

机构：Vall d'Hebron Institut de Recerca, Centro de Investigación Biomédica en Red, Vall d'Hebron Hospital Universitari, Research Network (United States), Centro de Investigación Biomédica en Red de Cáncer, Vall d'Hebron Institute of Oncology, Universidad de Navarra · ORCID：0000-0002-6031-535X

发表论文 32 篇 · 总被引 569 次 · h-index 13

代表论文

• Identification and experimental validation of druggable epigenetic targets in hepatoblastoma (2023 · Journal of Hepatology · 被引 53)
• Species delimitation using genomic data to resolve taxonomic uncertainties in a speciation continuum of pelagic seabirds (2022 · Molecular Phylogenetics and Evolution · 被引 29)
• The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent (2023 · Hepatology · 被引 28)
• PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity (2024 · Nature Communications · 被引 22)
• MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis (2024 · Cellular and Molecular Gastroenterology and Hepatology · 被引 19)
• Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD (2023 · Journal of Physiology and Biochemistry · 被引 17)